Relmada Therapeutics Announces Pricing of Upsized Public Offering of Common Stock

By WebmasterDecember 9, 2021November 1st, 2024No Comments

Relmada Therapeutics Announces Pricing of Upsized Public Offering of Common Stock

Previous PostRelmada Therapeutics Announces Closing of Public Offering and Full Exercise of Over-Allotment Option
Next PostAllianceChicago to Offer Wellsheet’s Predictive Clinical Workflow Platform Integrated with athenahealth’s EHR